ATE543495T1 - Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür - Google Patents
Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafürInfo
- Publication number
- ATE543495T1 ATE543495T1 AT06791135T AT06791135T ATE543495T1 AT E543495 T1 ATE543495 T1 AT E543495T1 AT 06791135 T AT06791135 T AT 06791135T AT 06791135 T AT06791135 T AT 06791135T AT E543495 T1 ATE543495 T1 AT E543495T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- ruthenium
- composition containing
- oxalato compound
- oxalato
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910052707 ruthenium Inorganic materials 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/256,175 US7648977B2 (en) | 2005-10-24 | 2005-10-24 | Pharmaceutical composition having a ruthenium oxalato compound and method of using the same |
| PCT/CN2006/002547 WO2007048311A1 (en) | 2005-10-24 | 2006-09-28 | Pharmaceutical composition having a ruthenium oxalato compound and method of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE543495T1 true ATE543495T1 (de) | 2012-02-15 |
Family
ID=37967402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06791135T ATE543495T1 (de) | 2005-10-24 | 2006-09-28 | Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7648977B2 (de) |
| EP (1) | EP1940385B1 (de) |
| CN (1) | CN101378748B (de) |
| AT (1) | ATE543495T1 (de) |
| WO (1) | WO2007048311A1 (de) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1109890A (en) * | 1965-12-21 | 1968-04-18 | Int Nickel Ltd | Preparation of finely divided metals |
| WO1995031202A1 (en) * | 1994-05-17 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Cage compounds, processes for their preparation and their use as antiviral agents |
| US5514995A (en) * | 1995-01-30 | 1996-05-07 | Micrel, Inc. | PCMCIA power interface |
| DE19736609A1 (de) * | 1997-08-22 | 1999-02-25 | Basf Ag | Verfahren zur Herstellung von Rutheniumkomplexen |
| JP4780834B2 (ja) * | 1998-10-22 | 2011-09-28 | フィリップ・ビー・ビー・モヘノ | 新規なプテリン抗新生物薬 |
| TWI228051B (en) * | 2003-05-19 | 2005-02-21 | Well Being Biochemical Corp | Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use |
-
2005
- 2005-10-24 US US11/256,175 patent/US7648977B2/en active Active
-
2006
- 2006-09-28 WO PCT/CN2006/002547 patent/WO2007048311A1/en active Application Filing
- 2006-09-28 CN CN2006800397999A patent/CN101378748B/zh active Active
- 2006-09-28 EP EP06791135A patent/EP1940385B1/de active Active
- 2006-09-28 AT AT06791135T patent/ATE543495T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1940385A1 (de) | 2008-07-09 |
| US20070105952A1 (en) | 2007-05-10 |
| WO2007048311A1 (en) | 2007-05-03 |
| CN101378748A (zh) | 2009-03-04 |
| EP1940385B1 (de) | 2012-02-01 |
| US7648977B2 (en) | 2010-01-19 |
| EP1940385A4 (de) | 2010-09-22 |
| CN101378748B (zh) | 2011-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013005478A (es) | Compuestos heterociclicos condensados antivirales. | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112012018670A2 (pt) | combinação, uso de um composto, composição farmacêutica, e, pacote de paciente | |
| ATE410424T1 (de) | Spirocyclische cyclohexan-derivate | |
| MX2010005292A (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. | |
| ATE530561T1 (de) | 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion | |
| NZ585226A (en) | Inhibitors of human immunodeficiency virus replication | |
| BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| EA201270666A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
| EA200801997A1 (ru) | Новые соединения | |
| EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| EA201101119A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
| EA200870223A1 (ru) | Производные бензоизоиндола для лечения боли | |
| DE602006012962D1 (de) | Pharmazeutische Zubereitungen von Ciprofloxacin | |
| MX2009005912A (es) | Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos. | |
| NO20055254D0 (no) | Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte | |
| MX2009006311A (es) | Terapia de combinacion para tratar infecciones de hepatitis c. | |
| ATE543495T1 (de) | Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür | |
| ATE487492T1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
| DE502007006951D1 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| DK1490049T3 (da) | Citalopram til behandling af forhöjet blodtryk | |
| SE0202287D0 (sv) | New compounds |